Charles G. Drake, MD, PhD | Authors


Investigating Immunotherapy Treatment in Renal Cell Carcinoma

June 22, 2018

Charles G. Drake, MD, PhD, director of Genitourinary Oncology at New York Presbyterian/Columbia University Medical Center, discusses his thoughts on whether sunitinib would be more successful as a treatment for patients with renal cell carcinoma if used in the neoadjuvant setting.